News

The Pharma Letter10m
UK science and innovation VC funding increases to £1.1 billion in 1st-qtr
According to property advisor Knight Frank, venture capital (VC) funding into the UK life sciences sector reached £1.1 ...
The Pharma Letter32m
J&J wins FDA approval for Imaavy to treat gMG
The US Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, ...